These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1927117)

  • 1. [The treatment of oligozoospermia with tamoxifen does not improve sperm quality].
    Sterzik K; Rosenbusch B; Grab D; Heyden M; Lichtenberger K; Wolf A
    Zentralbl Gynakol; 1991; 113(12):683-8. PubMed ID: 1927117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen treatment of oligozoospermia: a re-evaluation of its effects including additional sperm function tests.
    Sterzik K; Rosenbusch B; Mogck J; Heyden M; Lichtenberger K
    Arch Gynecol Obstet; 1993; 252(3):143-7. PubMed ID: 8503705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of idiopathic oligozoospermia with tamoxifen.
    Brigante C; Motta G; Fusi F; Coletta MP; Busacca M
    Acta Eur Fertil; 1985; 16(5):361-4. PubMed ID: 3936325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between follicle-stimulating hormone, luteinizing hormone, prolactin, and testosterone with sperm cell concentration and motility.
    Vasquez JM; Ben-Nun I; Greenblatt RB; Mahesh VB; Keel BA
    Obstet Gynecol; 1986 Jan; 67(1):86-90. PubMed ID: 3079622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A hormone assay as a therapeutic choice in male sterility].
    Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
    Schill WB; Reiter F; Korting HC; Schweikert HU
    Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
    Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
    Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
    Farmakiotis D; Farmakis C; Rousso D; Kourtis A; Katsikis I; Panidis D
    Fertil Steril; 2007 Oct; 88(4):847-53. PubMed ID: 17412336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between serum hormone levels and semen quality among men from an infertility clinic.
    Meeker JD; Godfrey-Bailey L; Hauser R
    J Androl; 2007; 28(3):397-406. PubMed ID: 17135633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract.
    Zalata A; Hafez T; Verdonck L; Vermeulen L; Comhaire F
    Int J Androl; 1995 Oct; 18(5):271-7. PubMed ID: 8567098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia.
    Hampl R; Heresová J; Lachman M; Sulcová J; Stárka L
    Exp Clin Endocrinol; 1988 Dec; 92(2):211-6. PubMed ID: 3243340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen citrate therapy in male infertility.
    AinMelk Y; Belisle S; Carmel M; Jean-Pierre T
    Fertil Steril; 1987 Jul; 48(1):113-7. PubMed ID: 3297810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of tamoxifen on the hormones and the sperm in 80 oligospermic and asthenospermic men].
    Buvat J; Gauthier A; Ardaens K; Buvat-Herbaut M; Lemaire A
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(3):407-15. PubMed ID: 6811649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with the antiestrogen tamoxifen in the therapy of oligozoospermia].
    Schill WB; Landthaler M
    Hautarzt; 1981 Jun; 32(6):306-8. PubMed ID: 7263237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia.
    Radicioni A; Paris E; Dondero F; Bonifacio V; Isidori A
    Acta Eur Fertil; 1994; 25(5):311-7. PubMed ID: 7660721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study.
    Foresta C; Bettella A; Garolla A; Ambrosini G; Ferlin A
    Fertil Steril; 2005 Sep; 84(3):654-61. PubMed ID: 16169399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.
    Tang KF; Zhao YL; Ding SS; Wu QF; Wang XY; Shi JQ; Sun F; Xing JP
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):191-7. PubMed ID: 25743120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic therapy of male subfertility].
    Maier U
    Wien Klin Wochenschr; 1989 Oct; 101(19):673-9. PubMed ID: 2618055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men.
    Cakan M; Aldemir M; Topcuoglu M; Altuğ U
    Urol Int; 2009; 83(4):446-51. PubMed ID: 19996653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia.
    Adamopoulos DA; Nicopoulou S; Kapolla N; Vassilopoulos P; Karamertzanis M; Kontogeorgos L
    Fertil Steril; 1995 Oct; 64(4):818-24. PubMed ID: 7672156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.